0 Yorumlar
0 hisse senetleri
861 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
- Please log in to like, share and comment!
- GLP-1 Receptor Agonist Market Is Driven By Growing Prevalence Of DiabetesThe GLP-1 receptor agonist market has been gaining popularity over the recent years owing to the growing prevalence of diabetes globally. GLP-1 receptor agonists act by increasing insulin secretion and reducing glucagon secretion in patients with type-2 diabetes. Some key advantages of GLP-1 receptor agonists include their ability to induce significant weight loss in patients and their low risk...0 Yorumlar 0 hisse senetleri 546 Views 0 önizleme
- GLP-1 Receptor Agonist Market Size, Analysis and Forecast 2031The GLP-1 Receptor Agonist Market in 2023 is US$ 14.44 billion, and is expected to reach US$ 23.58 billion by 2031 at a CAGR of 6.32%. FutureWise Research published a report that analyzes GLP-1 Receptor Agonist Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the...0 Yorumlar 0 hisse senetleri 71 Views 0 önizleme
- GLP-1 Receptor Agonists is fastest growing segment fueling the growth of GLP-1 Receptor Agonist MarketThe global GLP-1 Receptor Agonist Market is estimated to be valued at US$ 14319.85 Mn in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.Market Overview: GLP-1 receptor agonists are injectable drug products used for the treatment of type 2 diabetes. They work by stimulating the release of...0 Yorumlar 0 hisse senetleri 983 Views 0 önizleme
- Navigating The Future: Trends And Challenges In The GLP-1 Receptor Agonist MarketThe GLP-1 receptor agonist market, a critical segment of the pharmaceutical industry, is poised for significant transformations as it continues to address the needs of patients with type 2 diabetes. This dynamic market has seen impressive growth and innovation, but it also faces unique challenges that warrant attention and proactive strategies. Combination Therapies: Combination therapies,...0 Yorumlar 0 hisse senetleri 950 Views 0 önizleme
- The global GLP-1 Receptor Agonist Market is estimated to be valued at US$12,720.6 million in 2021 and is expected to exhibit a CAGR of 6.1% over the forecast period 2021-2028GLP-1 receptor agonists are a class of medications used in the treatment of type 2 diabetes. They work by mimicking the action of GLP-1, a hormone that stimulates insulin release and lowers blood sugar levels. These medications have been shown to effectively control blood sugar levels, reduce weight, and lower the risk of cardiovascular events in patients with type 2 diabetes.Market DynamicsThe...0 Yorumlar 0 hisse senetleri 924 Views 0 önizleme